Product NDC: | 0409-3863 |
Proprietary Name: | Foscarnet Sodium |
Non Proprietary Name: | Foscarnet Sodium |
Active Ingredient(s): | 24 mg/mL & nbsp; Foscarnet Sodium |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-3863 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077174 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100707 |
Package NDC: | 0409-3863-05 |
Package Description: | 12 BOTTLE, GLASS in 1 CASE (0409-3863-05) > 500 mL in 1 BOTTLE, GLASS |
NDC Code | 0409-3863-05 |
Proprietary Name | Foscarnet Sodium |
Package Description | 12 BOTTLE, GLASS in 1 CASE (0409-3863-05) > 500 mL in 1 BOTTLE, GLASS |
Product NDC | 0409-3863 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Foscarnet Sodium |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20100707 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | FOSCARNET SODIUM |
Strength Number | 24 |
Strength Unit | mg/mL |
Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Pyrophosphate Analog [Chemical/Ingredient],Pyrophosphate Analog DNA Polymerase Inhibitor [EPC] |